Good Start Genetics Appoints Chief Financial Officer

Seasoned financial executive, Marc Jones, added to company’s
leadership team

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Good
Start Genetics®, Inc.
, a commercial-stage molecular genetics
information company, announced today that it has appointed Marc Jones to
the post of chief financial officer (CFO). As CFO, Jones will lead Good
Start Genetics’ financial operations and investor relations, and support
the executive team to drive overall corporate strategy.

“Good Start Genetics is a leader in providing innovative and affordable
technologies supportive of the reproductive health community,” said
Jones. “Given its established presence in reproductive health and an
exciting pipeline of products on the horizon, I look forward to helping
drive Good Start Genetics’ expanding business to fulfill both its
financial goals and its mission to prepare families for tomorrow.”

Jones has held a number of other corporate finance positions ranging
from Fortune 50 companies to dot-com startups. Jones joins Good Start
Genetics from T2 Biosystems (NASDAQ: TTOO), a company focused on
developing diagnostic products to improve patient health. While with T2
Biosystems, he helped raise nearly $100 million in capital and led the
public offering. Previously, Jones served as chief financial officer of
Crashlytics, Ivenix and CHiL Semiconductor.

“Marc brings extensive expertise in managing all financial aspects and
business strategy for both large and small, public and private
healthcare and technology organizations,” said Don Hardison, president
and CEO of Good Start Genetics. “We are very excited to work with Marc
in his new role and expect him to help us foster unprecedented growth
for our company and, ultimately, help more couples prepare for their
pregnancies and healthy families.”

About Good Start Genetics®, Inc.
Good Start Genetics is a
molecular genetics information company transforming the standard of care
in reproductive and family medicine. Its suite of reproductive genetics
products provides clinicians and patients with insightful and actionable
information in order to promote successful pregnancies and healthy
families. Its flagship genetic carrier screening service, GeneVu™,
is a comprehensive menu of highly-accurate tests for known and novel
mutations that cause inherited genetic disorders, and its advanced
preimplantation genetic screening test, EmbryVu™, is helping a
wider range of couples find their paths to pregnancy at significantly
lower costs. Good Start Genetics complements these tests and its
proprietary next-generation DNA sequencing (NGS) capabilities with
world-class customer care and thoughtful genetic counseling to help
families prepare for tomorrow. For more information, please visit www.goodstartgenetics.com
or join us on Facebook,
Twitter
and LinkedIn.

Contacts

Good Start Genetics
Bob Rochelle, 617-714-0825
brochelle@gsgenetics.com
or
Racepoint
Global
Jeff Stoecker, 617-624-3424
goodstartgenetics@racepointglobal.com